One of the most prominent examples of lncRNAs in clinical practice is also PCA3 (Prostate Cancer Antigen 3), an FDA-approved biomarker for prostate cancer diagnosis, which outperforms traditional PSA testing in specificity [116]. Here, PCA3 is linked to prostate cancer.